-
What topics/experts would you like to see on The Breastcancer.org Podcast?
Hello, I'm Jamie, senior editor at Breastcancer.org and host of The Breastcancer.org Podcast. I'd like to make sure the podcast is answering questions that Community members have. Are there topics you'd like to see covered? Experts you think I should talk to? Do you want to share your story? Questions you want answered?…
-
TNBC Can Change Hormone Receptor Status If It Comes Back
Sep 23, 2025 Triple-negative breast cancer may come back as hormone receptor-positive disease about a third of the time. Triple-negative breast cancer is negative for both estrogen and progesterone receptors. So, it’s hormone receptor-negative. People diagnosed with this type of breast cancer aren’t offered hormonal…
-
Breastcancer.org Podcasts: Experts discuss research & issues
Our podcasts feature experts discussing a wide variety of breast cancer issues and the latest research on breast cancer. Check out all of Breastcancer.org's Podcasts here. In the premiere podcast, we're excited to bring you a summary of the research highlights from first day of the San Antonio Breast Cancer Symposium 2013!…
-
Managing Hormonal Therapy Side Effects
Jun 11, 2025 World-renowned breast cancer expert Dr. Hope Rugo offers strategies for the most troubling side effects. At the 2025 American Society of Clinical Oncology Annual Meeting, Hope Rugo, MD, chaired a session on managing the side effects of new breast cancer treatments and also presented information on how to…
-
Chelsea’s Story: Diagnosed With Breast Cancer at 25
Sep 9, 2025 After genetic testing showed she had a BRIP1 mutation, Chelsea Vangrol’s doctor sent her for a baseline mammogram at age 25. A medical assistant at Elizabeth Wende Breast Care in Upstate New York, Chelsea Vangrol had seen young women diagnosed with breast cancer. But she never expected to be one of them. She…
-
Teaching the Immune System to Fight Cancer
Aug 22, 2025 A new type of drug may be able to make the immune system attack cancer. Dr. Benjamin Schrank explains his research. Antibody-drug conjugates (ADCs) are a relatively new type of medicine for breast cancer. Enhertu (chemical name: fam-trastuzumab-deruxtecan-nxki) and Dato-DXd (brand name: Datroway) are two ADCs…
-
Diagnosed With Breast Cancer While Pregnant
Aug 8, 2025 Rafaela Dreisin shares her journey through diagnosis, treatment, and giving birth. At the start of her second trimester, Rafaela Dreisin was diagnosed with breast cancer at the age of 36. Listen to the episode to hear Rafaela discuss: how she and her doctors decided on a treatment plan how she coped with…
-
Health Insurance and Disability for People Living With Metastatic Breast Cancer
Jul 25, 2025 Triage Cancer CEO Joanna Doran answers questions on how people with metastatic disease can best navigate health insurance and disability issues. This podcast is the audio from a special Virtual Support Group meetup featuring guest moderator Joanna Doran. Listen to the podcast to hear Joanna and Community…
-
Managing the Emotions of Metastatic Breast Cancer When You’re Young
Jul 11, 2025 Therapist Kelly Grosklags helps Melissa Jenkins moderate a special Virtual Community Meetup on managing the emotions you feel after being diagnosed with metastatic breast cancer at a young age. This podcast is the audio from a special Virtual Support Group featuring guest moderator Kelly Grosklags. Listen to…
-
Breast Cancer Doesn’t Care Whom You Love
Jun 27, 2025 Jaci Field, a member of the LGBTQ+ community, shares her story. Four years after giving birth to her son, Jaci Field was diagnosed with breast cancer at age 39. Listen to the episode to hear Jaci discuss: her breast cancer experience and her advocacy work the discrimination she’s faced, both because of her…
-
Financial Toxicity and Breast Cancer: How Doctors Can Help
Financial Toxicity and Breast Cancer: How Doctors Can Help Dr. Fumiko Chino offers advice and suggestions on how to navigate financial difficulties. Jun 3, 2025 At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Fumiko Chino, MD, summarized her presentation on how doctors can help the people they care…
-
Making Sure Exercise is Part of Cancer Care
Making Sure Exercise is Part of Cancer Care Dr. Katie Schmitz discusses how to integrate exercise into care treatment plans, as well as a study showing exercise improved survival in people with colon cancer. Jun 2, 2025 At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Katie Schmitz chaired a…
-
Top Breast Cancer Research at ASCO 2025
Top Breast Cancer Research at ASCO 2025 Dr. Eleonora Teplinsky explains DESTINY-Breast09, ASCENT-04, and SERENA-6. Jun 2, 2025 The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting featured five days of presentations and educational sessions on all types of cancer. Dr. Eleonora Teplinsky, a board-certified…
-
The Research METAvivor Funds
The Research METAvivor Funds METAvivor President Dr. Kelly Shanahan discusses the research the organization supports. May 16, 2025 By 2030, researchers estimate that about 246,000 people will be living with metastatic breast cancer. METAvivor is the first organization dedicated to raising awareness of, and funding research…
-
How Is the NIH Funding Freeze Affecting Breast Cancer Research? One Scientist Explains
How Is the NIH Funding Freeze Affecting Breast Cancer Research? One Scientist Explains Noted scientist Donald McDonnell explains how the halt in NIH funding is hampering breast cancer research. Mar 21, 2025 The National Institutes of Health (NIH) are the largest funder of cancer research in the world. A January 2025…
-
Triple-Negative Breast Cancer and the TRIM37 Protein
Triple-Negative Breast Cancer and the TRIM37 Protein Is the TRIM37 protein one reason why Black women are more likely to be diagnosed with triple-negative breast cancer? Dr. Sanchita Bhatnagar discusses her research. Apr 4, 2025 It’s been known for many years that Black women are twice as likely as white women to be…
-
Winter 2025 Breast Cancer Research Round Up
Winter 2025 Breast Cancer Research Round Up Have you been diagnosed with metastatic hormone receptor-positive breast cancer or DCIS? Dr. Kevin Fox discusses the latest research. Apr 18, 2025 Can people diagnosed with metastatic hormone receptor-positive breast cancer avoid chemotherapy and take a CDK4/6 inhibitor instead?…
-
Lifestyle Risk Factors and Breast Cancer Mortality
Lifestyle Risk Factors and Breast Cancer Mortality Dr. Samantha El Warrak’s research found that a diet high in red meat was most linked to dying from breast cancer. May 27, 2025 At the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, Dr. Samantha El Warrak presented the results of her research on how five…
-
Breast Cancer Doesn’t Care About Gender
Breast Cancer Doesn’t Care About Gender What is it like to be a member of the trans community and diagnosed with breast cancer? Ash Davidson shares his story. May 2, 2025 Ashton Davidson was diagnosed with breast cancer during gender-affirming top surgery. He faced some unique challenges and situations during and after…
-
Triple-Negative Breast Cancer Treatment: Where Are We?
Triple-Negative Breast Cancer Treatment: Where Are We? Dr. Lisa Carey explains the latest research on TNBC treatments. Mar 7, 2025 About 10% to 15% of breast cancers are triple-negative. This means they don’t have receptors for the hormones estrogen or progesterone, and don’t have too many HER2 proteins. So, hormonal…
-
How Does Alcohol Affect Breast Cancer Risk?
How Does Alcohol Affect Breast Cancer Risk?Feb 21, 2025 About half the country doesn’t know that alcohol increases cancer risk. In January 2025, the U.S. Surgeon General put out an advisory on alcohol and cancer risk, calling for cancer risk-warning labels on alcoholic beverages. The advisory said alcohol contributes to…
-
Fall 2024 Breast Cancer Research Round Up
Fall 2024 Breast Cancer Research Round UpFeb 7, 2025 What does the latest breast cancer research mean for you? Dr. Kathy Miller explains. Hormonal birth control increases breast cancer risk in women with a BRCA1 mutation, but not women with a BRCA2 mutation. Levonorgestrel IUDs increase risk, but how much? The long-term…
-
Biomarker Testing Laws: How Are They Helping?
Biomarker Testing Laws: How Are They Helping? Float RightMediumAccessibilityDelete Jan 24, 2025 Joanna Doran explains new laws aimed at providing more comprehensive insurance coverage for biomarker testing. In cancer, biomarkers are features of the tumor, such as a genetic mutation or the presence of a certain protein.…
-
Advocates’ Thoughts on SABCS 2024
Advocates’ Thoughts on SABCS 2024 Dec 13, 2024 What are patient advocates excited about at SABCS 2024? Five tell us. Five patient advocates share what they like and what they’re excited about at the 2024 San Antonio Breast Cancer Symposium. The advocates are: Antoinette Greer, of My Sister My Friend Breast Cancer Support…
-
Top Research at SABCS 2024
Top Research at SABCS 2024 Dec 13, 2024 What were the hot topics at the 2024 SABCS? Dr. Marisa Weiss details the highlights. The 2024 San Antonio Breast Cancer Symposium featured five days of research presentations, educational sessions, and advocacy meetings. Dr. Marisa Weiss, founder and chief medical officer of…
-
Enhertu for HER2-Low and -Ultralow Metastatic Breast Cancer
Enhertu for HER2-Low and -Ultralow Metastatic Breast Cancer Dec 12, 2024 Dr. Aditya Bardia discusses Enhertu for metastatic hormone receptor-positive, HER2-low and -ultralow breast cancer and explains those terms. At the 2024 San Antonio Breast Cancer Symposium, Dr. Aditya Bardia, director of the Breast Oncology Program…
-
Breast Cancer in Young Women: What We Know and Reducing Risk
Breast Cancer in Young Women: What We Know and Reducing Risk Dec 11, 2024 Dr. Matteo Lambertini discusses current research on breast cancer in women 40 and younger. Cases of breast cancer in young women have been increasing dramatically in the last eight years. Dr. Matteo Lambertini, whose research focuses on breast cancer…
-
Alamo Breast Cancer Foundation Scholarships
Alamo Breast Cancer Foundation Scholarships Dec 11, 2024 What does it take to be an Alamo Breast Cancer Scholar? Andrea Hans explains. Andrea Hans was diagnosed with stage II triple-negative breast cancer when she was 28. With expertise in public health and health policy, she began working as an advocate to empower young…
-
Sexual Health After Breast Cancer
Sexual Health After Breast Cancer Dec 10, 2024 Noted sexpert Dr. Don Dizon explains why sexual health after cancer treatment should be more than an afterthought. At the 2024 San Antonio Breast Cancer Symposium Dr. Don Dizon, professor of medicine and professor of surgery at the Brown University Cancer Institute, was part…
-
Can Hormonal Therapy Help Treat Triple-Negative Breast Cancer?
Can Hormonal Therapy Help Treat Triple-Negative Breast Cancer? Dec 6, 2024 Dr. Donald McDonnell discusses his research on estrogen, eosinophils, and triple-negative breast cancer. New research suggests that estrogen plays a role in allowing hormone receptor-negative breast cancer to grow. This is because estrogen limits…